Stock Research for ATTBF

ATTBF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ATTBF Stock Chart & Research Data

The ATTBF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATTBF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ATTBF Due diligence Resources & Stock Charts

The ATTBF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ATTBF Detailed Price Forecast - CNN Money CNN View ATTBF Detailed Summary - Google Finance
Yahoo View ATTBF Detailed Summary - Yahoo! Finance Zacks View ATTBF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ATTBF Trends & Analysis - Trade-Ideas Barrons View ATTBF Major Holders - Barrons
NASDAQ View ATTBF Call Transcripts - NASDAQ Seeking View ATTBF Breaking News & Analysis - Seeking Alpha
Spotlight View ATTBF Annual Report - CompanySpotlight.com OTC Report View ATTBF OTC Short Report - OTCShortReport.com
TradeKing View ATTBF Fundamentals - TradeKing Charts View ATTBF SEC Filings - Bar Chart
WSJ View Historical Prices for ATTBF - The WSJ Morningstar View Performance/Total Return for ATTBF - Morningstar
MarketWatch View the Analyst Estimates for ATTBF - MarketWatch CNBC View the Earnings History for ATTBF - CNBC
StockMarketWatch View the ATTBF Earnings - StockMarketWatch MacroAxis View ATTBF Buy or Sell Recommendations - MacroAxis
Bullish View the ATTBF Bullish Patterns - American Bulls Short Pains View ATTBF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ATTBF Stock Mentions - StockTwits PennyStocks View ATTBF Stock Mentions - PennyStockTweets
Twitter View ATTBF Stock Mentions - Twitter Invest Hub View ATTBF Investment Forum News - Investor Hub
Yahoo View ATTBF Stock Mentions - Yahoo! Message Board Seeking Alpha View ATTBF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ATTBF - SECform4.com Insider Cow View Insider Transactions for ATTBF - Insider Cow
CNBC View ATTBF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ATTBF - OTC Markets
Yahoo View Insider Transactions for ATTBF - Yahoo! Finance NASDAQ View Institutional Holdings for ATTBF - NASDAQ


Stock Charts

FinViz View ATTBF Stock Insight & Charts - FinViz.com StockCharts View ATTBF Investment Charts - StockCharts.com
BarChart View ATTBF Stock Overview & Charts - BarChart Trading View View ATTBF User Generated Charts - Trading View




Latest Financial News for ATTBF


Abattis Bioceuticals Offers Comfort to Those Suffering with Chronic Pain & Inflammation -- CFN Media
Posted on Tuesday October 30, 2018

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering the launch of Abattis Bioceuticals Corp.'s (ATT.CN) (ATTBF) latest product innovation. “Comfort”, a nutraceutical designed to alleviate chronic pain and inflammation, is the first in line of a dozen new products the company expects to launch over 36 months. According to a recent Institute of Medicine Report: Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, stated, “Acute or chronic pain is a significant public health problem that costs society at least $560-$635 billion annually in North America alone.


Abattis Bioceuticals Announces Board Change
Posted on Friday October 19, 2018

Vancouver, British Columbia--(Newsfile Corp. - October 19, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTC Pink: ATTBF) (the "Company" or "Abattis") is pleased to announce the additions of Kent McParland and Cedric Wilson to the Board of Directors (the "Board"). Mr. McParland and Mr. Wilson replace Cameron Paddock and Rene David who have left Abattis to concentrate on other ventures. Mr. McParland is a Chartered Professional Accountant experienced in multiple industries and geographical locations. ...


Abattis Bioceuticals Celebrates Legalization
Posted on Wednesday October 17, 2018

Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (ATTBF) is pleased to celebrate the legalization of cannabis in Canada. This is a truly a newsworthy day in Canadian history, as we formally recognize the end of cannabis prohibition in our country. As Ottawa subsequently, decreed Legalization on Oct.17th, 2018 - Canada is now the second country in the world, and first G7 nation to legalize marijuana production, sale and consumption country-wide.


Abattis Bioceuticals Provides Update on Vaporizer Product Line
Posted on Thursday October 11, 2018

Abattis Bioceuticals Corp. (the “Company" or "Abattis") (CSE:ATT) (ATTBF) is pleased to announce an update on our recent product line addition of three new vaporizers. The “VB-2” uses a compact 350mAh variable voltage battery, designed with built-in protections against short-circuiting and overheating, and features a conventional preheating function that the user activates with two clicks of a button. The cutting-edge device is equipped with a 510-threaded connection that can be closed to house attachments and features a built-in USB charging cable, a long-lasting embedded 350mAh lithium ion battery, a key ring and an LED light indicator.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.